Article ; Online: Toxicities, intensive care management, and outcome of chimeric antigen receptor T cells in adults: an update.
Critical care (London, England)
2024 Volume 28, Issue 1, Page(s) 69
Abstract: Background: Chimeric antigen receptor T cells are a promising new immunotherapy for haematological malignancies. Six CAR-T cells products are currently available for adult patients with refractory or relapsed high-grade B cell malignancies, but they are ...
Abstract | Background: Chimeric antigen receptor T cells are a promising new immunotherapy for haematological malignancies. Six CAR-T cells products are currently available for adult patients with refractory or relapsed high-grade B cell malignancies, but they are associated with severe life-threatening toxicities and side effects that may require admission to ICU. Objective: The aim of this short pragmatic review is to synthesize for intensivists the knowledge on CAR-T cell therapy with emphasis on CAR-T cell-induced toxicities and ICU management of complications according to international recommendations, outcomes and future issues. |
---|---|
MeSH term(s) | Adult ; Humans ; Receptors, Chimeric Antigen/therapeutic use ; B-Lymphocytes ; Critical Care ; Hematologic Neoplasms/therapy ; T-Lymphocytes |
Chemical Substances | Receptors, Chimeric Antigen |
Language | English |
Publishing date | 2024-03-05 |
Publishing country | England |
Document type | Journal Article ; Review |
ZDB-ID | 2041406-7 |
ISSN | 1466-609X ; 1364-8535 |
ISSN (online) | 1466-609X |
ISSN | 1364-8535 |
DOI | 10.1186/s13054-024-04851-0 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5517: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.